At BioMarin, we seek the big effect – for our patients, employees, community and environment. These four pillars are the foundation on which we conduct our day-to-day operations and business practices. With our patients at the heart of everything we do, we strive to pioneer a more sustainable, inclusive and compassionate tomorrow.
To Our Patients: Advancing Comprehensive Care
Everything we do is focused on our patients, and we always have their best interests in mind. Each one drives our efforts to find ways to provide them and their families with access to treatments, disease education and comprehensive patient support services. We recognize the importance of integrating the patient voice starting at research and development and continuing even after a medicine is approved to best serve the unique needs of
- Patient support programs that address care beyond the therapy, such as grocery store tours exploring low-phe food options for those with PKU
- Close collaboration with rare disease and patient advocates
- RARE Scholars, an annual scholarship for students living with rare disease, to empower patients with continued education
- Expanded access to therapies through our Compassionate Use Policy
- Grants and funding for a variety of events, activities and projects that educate patients and raise awareness about rare disease
- Support for Investigator Initiated Studies to advance scientific innovation for rare diseases and genetic disorders
To Our Employees: Fostering Innovation and Inclusion
More than two decades ago, BioMarin began by embracing difference – acknowledging and addressing the unmet medical needs of people with rare genetic diseases. Today, this ethos extends across our company, where we believe in fostering a diverse and inclusive community of employees. We seek diverse perspectives and value contributions from those with a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge. At BioMarin, we are passionate about making a big impact on rare patient populations, and this takes the widest possible range of ideas. To find solutions for the patients we serve, our workforce must represent diversity in all its forms.
- Understand, support, and celebrate our differences in race, ethnicity, gender, age, religion, disability, and sexual orientation
- Adhere to a Global Code of Conduct and Business Ethics to conduct all aspects of our business in accordance with the highest standards of ethical behavior
- Provide an open-door policy and EthicsPoint hotline that allows employees to ask questions or submit potential policy violations
- Support employee resource groups and events that reflect the needs of our employees, such as PRIDE and BioMarin Women’s Leadership Development (BWLD)
- Participate in the Western Regional Minority Supplier Development Council (WRMSDC), providing access to certified minority suppliers, supplier diversity program development, and more
To Our Community: Investing in the Next Pioneers
We are proud members of our community and believe that giving back starts at home. Our passion is the science, so we’ve funneled our philanthropic giving into programs that encourage science education and the development of the next generation of pioneers.
- An ongoing commitment to supporting BioTech Partners, an independent, non-profit, Bay Area-based organization focused on helping students underrepresented in the field of biotechnology to attain personal, academic, and professional development experiences through in-classroom instruction and paid internships within the biotech and health industries
- Sponsorship of the Mill Valley Film Festival to elevate the power of storytelling and voices of our community
- Additional grants and donations that provide funding for a variety of events, activities, and projects that support patients, the scientific or medical community, and/or public health in areas of legitimate interest to BioMarin
To the Environment: Building a Sustainable, Healthy Future
It’s up to us to protect our planet. As global citizens, we strive to operate in a way that protects the environment and provides a safe and healthful workplace for personnel and the communities that we serve.
- Green buildings that have been constructed to exceed the State of California’s Energy
- Efficiency Standards for Nonresidential Buildings
- A $16M remediation of 999 3rd Street in San Rafael, a former PG&E Manufactured Gas Plant site, to remove toxic materials and build senior housing for the community, a donation of $1.2M in land value
- Efforts to exclude conflict minerals, such as gold, tungsten, tin, and tantalum, from our products and supply chain
- Safe and secure disposal of unused or unwanted medications and medical waste
- Training and information on chemical substances, hazardous substances and hazardous waste
- Reduction of water consumption and improved efficiency of water utilities, including computerized sensors and automatic isolation valves
- Purchase of renewable electricity from Marin Clean Energy that reduces greenhouse gas emissions
- Use of a clean, natural-gas-fired co-generation system at the Novato manufacturing facility
- Protection of a safe and healthful workplace
- Recycling of cardboard and use of reusable containers for bioprocessing materials
- Environmental Health, Safety and Sustainability (EHS&S): BioMarin is committed to operating in a manner that protects the environment and provides a safe and healthful workplace for personnel and the communities in which we operate. Our Ireland manufacturing site is certified to ISO 14001 Environmental Management Systems and ISO 45001 Occupational Health and Safety Management Systems standards. Our Northern California manufacturing site also conforms to management system standards for environmental and occupational health and safety. All employees are encouraged to submit incidents, near misses, and good catches into our global incident management system. See BioMarin’s Global EHS&S Policy.
- Global Trade and Transport: BioMarin manages its operations and global supply chain in compliance with applicable export, import, and trade compliance laws, including those related to trade embargoes and economic sanctions, export control, boycott, cargo security, import classification and valuation, origin, marking, and free trade agreements to meet the needs of its patients and shareholders.
- Human Trafficking and Slavery: BioMarin is committed to keeping its supply chain and operations free from human slavery, human trafficking, and forced labor. For more information or to view our statement regarding human trafficking, see BioMarin’s California Transparency in Supply Chains and UK Modern Slavery Act Statement.
- Product Quality and Safety: BioMarin complies with all regulations and laws pertaining to reporting on adverse events (AE) and special situation events (SSE). Any BioMarin employee who becomes aware of an AE or SSE must forward certain enumerated information within one business day to the Pharmacovigilance department.
- Clinical Trials Practices: BioMarin is committed to the safety of patients and meeting all GxP regulations and policies.
- Good Laboratory Practices
- Human Subject Protection in Clinical Research
- BioMarin-sponsored clinical trials are designed and conducted in accordance with all applicable laws and regulations.
- Policies on ethical research are regularly reviewed and updated.
- A monitoring and review system is in place.
- All BioMarin-sponsored clinical trials are prospectively reviewed by a qualified Institutional Review Board or Independent Ethics Committee.
- Responsible Sales and Marketing: BioMarin is committed to fair competition as a matter of corporate conduct. We abide by all laws that apply to marketing activities, including prohibiting:
- False or misleading advertising;
- Bribery of competitors’ or customers’ employees, and
- Unfair comments about competitors’ products.